bioRxivPharmacology & Toxicology
Natural variation in Caenorhabditis elegans responses to the anthelmintic emodepside
Abstract
Treatment of parasitic nematode infections depends primarily on the use of anthelmintics. However, this drug arsenal is limited, and resistance against most anthelmintics is widespread. Emodepside is a new anthelmintic drug effective against gastrointestinal and filarial nematodes. Nematodes that are resistant to other anthelmintic drug classes are susceptible to emodepside, indicating that the emodepside mode of action is distinct from previous anthelmintics. The laboratory-adapted Caenorhabditis elegans strain N2 is sensitive to emodepside, and genetic selection and in vitro experiments implicated slo-1, a BK potassium channel gene, in emodepside mode of action. In an effort to understand how natural populations will respond to emodepside, we measured brood sizes and developmental rates of wild C. elegans strains after exposure to the drug and found natural variation across the species. Some of the observed variation in C. elegans emodepside responses correlates with amino acid substitutions in slo-1, but genetic mechanisms other than slo-1 coding variants likely underlie emodepside resistance in wild C. elegans strains. Additionally, the assayed strains have higher offspring production in low concentrations of emodepside (a hormetic effect), which could impact treatment strategies when parasites are underdosed. We find that natural variation affects emodepside sensitivity, supporting the suitability of C. elegans as a model system to study emodepside responses across natural nematode populations. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=135 SRC="FIGDIR/small/425329v2_ufig1.gif" ALT="Figure 1"> View larger version (18K): org.highwire.dtl.DTLVardef@1139cf4org.highwire.dtl.DTLVardef@a56a30org.highwire.dtl.DTLVardef@1de8b2forg.highwire.dtl.DTLVardef@183e4a6_HPS_FORMAT_FIGEXP M_FIG C_FIG HighlightsO_LIEmodepside responses vary across the C. elegans species. C_LIO_LIWild strains of C. elegans model natural differences in parasite emodepside responses. C_LIO_LIVariation in the emodepside target slo-1 and other loci correlate with resistance. C_LIO_LILow doses of emodepside cause a hormetic effect on offspring production. C_LI
- organism: C. elegans
- research focus: host-pathogen & immune response
- research focus: cell type annotation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Variation in anthelmintic responses are driven by genetic differences among diverse C. elegans strains
Amanda O. Shaver, Janneke Wit, … Erik C. Andersen·PLoS PathogensPeer-reviewed·Apr 3, 2023
- Evolution of ivermectin resistance in the nematode model Caenorhabditis elegans: critical influence of population size and unexpected cross-resistance to emodepside
Jacqueline R. Hellinga, Barbora Trubenová, … Georg von Samson‐Himmelstjerna·Evolutionary ApplicationsPeer-reviewed·Apr 1, 2026
- Discovery of unique loci that underlie nematode responses to benzimidazoles
Mostafa Zamanian, Daniel E. Cook, … Erik C. Andersen·PLoS neglected tropical diseasesPeer-reviewed·Mar 30, 2018
- Mapping resistance-associated anthelmintic interactions in the model nematode Caenorhabditis elegans
E. G. Rehborg, N. J. Wheeler, M. Zamanian·bioRxiv·Apr 26, 2023
- Two novel loci underlie natural differences in Caenorhabditis elegans macrocyclic lactone responses
Kathryn S. Evans, Janneke Wit, … Erik C. Andersen·PLoS PathogensPeer-reviewed·Mar 15, 2021
- Modulation of serotonergic, dopaminergic and tubulin-associated pathways by tannin-free natural products in Caenorhabditis elegans reveals effective anthelmintic drug targets
Rajiur Rahaman Rabbi, Nurnabi Ahmed, … Md Hasanuzzaman Talukder·bioRxiv·Oct 5, 2025